Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/12/2026 | Q4 | $1.9M | -- | -- | -- | -- |
| 11/13/2025 | Q3 | $1.6M | $1.2M | -$0.10 | -- | -- |
| 08/14/2025 | Q2 | $1.6M | $1.3M | -$0.10 | -- | -- |
| 05/15/2025 | Q1 | $1.3M | $1.6M | -$0.11 | -- | -- |
| 03/13/2025 | Q4 | $1.5M | $1.3M | -$0.18 | -- | -- |
| 11/14/2024 | Q3 | $2M | $1.4M | -$0.14 | -- | -- |
| 08/14/2024 | Q2 | $2.6M | $1.1M | -$0.62 | -$0.08 | -$0.54 |
| 05/10/2024 | Q1 | $2.4M | $2M | -$0.16 | -$0.13 | -$0.03 |
| 03/28/2024 | Q4 | $2.1M | $1.1M | -$0.31 | -$0.13 | -$0.19 |
| 11/09/2023 | Q3 | -- | -- | -$0.17 | -$0.15 | -$0.02 |
| 08/08/2023 | Q2 | -- | -- | -$0.14 | -$0.18 | $0.04 |
| 05/10/2023 | Q1 | -- | -- | -$0.16 | -$0.12 | -$0.04 |
| 03/01/2023 | Q4 | -- | -- | -$0.17 | -$0.14 | -$0.03 |
| 11/09/2022 | Q3 | -- | -- | -$0.15 | -$0.14 | -$0.01 |
| 08/09/2022 | Q2 | -- | -- | -$0.16 | -$0.12 | -$0.04 |
| 05/10/2022 | Q1 | -- | -- | -$0.16 | -$0.14 | -$0.02 |
| 03/01/2022 | Q4 | -- | -- | -$0.27 | -$0.12 | -$0.15 |
| 11/08/2021 | Q3 | -- | -- | -$0.13 | -- | -- |
| 08/09/2021 | Q2 | -- | -- | -$0.14 | -$0.10 | -$0.04 |
| 05/10/2021 | Q1 | -- | -- | -$0.12 | -$0.10 | -$0.03 |
| 03/15/2021 | Q4 | -- | -- | -$0.09 | -$0.11 | $0.02 |
| 11/09/2020 | Q3 | -- | -- | -$0.13 | -$0.12 | -$0.01 |
| 08/10/2020 | Q2 | -- | -- | -$0.13 | -$0.11 | -$0.02 |
| 05/11/2020 | Q1 | -- | -- | -$0.18 | -- | -- |
| 03/16/2020 | Q4 | -- | -- | -$0.31 | -$0.15 | -$0.16 |
| 11/07/2019 | Q3 | -- | -- | -$0.18 | -$0.16 | -$0.02 |
| 08/09/2019 | Q2 | -- | -- | -$0.20 | -$0.18 | -$0.02 |
| 05/09/2019 | Q1 | -- | -- | -$0.25 | -$0.22 | -$0.03 |
| 03/15/2019 | Q4 | -- | -- | -$0.22 | -- | -- |
| 11/08/2018 | Q3 | -- | -- | -$0.19 | -$0.20 | $0.01 |
| 08/09/2018 | Q2 | -- | -- | -$0.24 | -- | -- |
| 05/10/2018 | Q1 | -- | -- | -$0.22 | -- | -- |
| 03/19/2018 | Q4 | -- | -- | -$0.29 | -- | -- |
| 11/10/2017 | Q3 | -- | -- | -$0.28 | -- | -- |
| 08/09/2017 | Q2 | -- | -- | -$0.22 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$0.23 | -- | -- |
| 03/17/2017 | Q4 | -- | -- | -$0.32 | -- | -- |
| 11/14/2016 | Q3 | -- | -- | -$0.32 | -- | -- |
| 08/15/2016 | Q2 | -- | -- | -$0.28 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$0.26 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$0.24 | -- | -- |
Vuzix Corp. reported $1.2M worth of top line sales in its most recent quarter.
Vuzix Corp. announced earnings per share of -$0.10 which represents a miss of analyst forecast a -- per share.
Vuzix Corp. reported -$1.2M that represents -$0.02 per share over the last quarter.
Vuzix Corp.'s earnings are forecast to decrease from -$1.08 per share to -$0.60 per share next year representing a decrease of -46.84%.
Vuzix Corp.'s next earnings date is March 12, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.